| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |